TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
WP2857	Mesodermal Commitment Pathway	0.00252171686636919	-5.98281531325744	156	16	0.0634920634920635	252	5358	58499,8320,79668,10413,6657,3720,51701,1488,92,9314,5915,5090,9241,154091,10124,406911	ZNF462,EOMES,PARP8,YAP1,SOX2,JARID2,NLK,CTBP2,ACVR2A,KLF4,RARB,PBX3,NOG,SLC2A12,ARL4A,MIR125B1
WP2858	Ectoderm Differentiation	0.00293689869046859	-5.83040112158307	144	15	0.0595238095238095	252	5358	5783,5787,91653,51701,2263,6657,5420,2534,101928583,1006,2737,7903,9079,1501,10486	PTPN13,PTPRB,BOC,NLK,FGFR2,SOX2,PODXL,FYN,SLC7A14-AS1,CDH8,GLI3,ST8SIA4,LDB2,CTNND2,CAP2
WP3853	ERK Pathway in Huntington's Disease	0.00329041322018055	-5.71674212325266	14	4	0.0158730158730159	252	5358	5594,1956,2911,4915	MAPK1,EGFR,GRM1,NTRK2
WP1539	Angiogenesis	0.00450229767144068	-5.40316741886096	24	5	0.0198412698412698	252	5358	284,3791,5594,7010,2263	ANGPT1,KDR,MAPK1,TEK,FGFR2
WP2795	Cardiac Hypertrophic Response	0.00477976378158369	-5.34336415177861	57	8	0.0317460317460317	252	5358	3084,5594,9734,6885,2932,5587,2263,5607	NRG1,MAPK1,HDAC9,MAP3K7,GSK3B,PRKD1,FGFR2,MAP2K5
WP1544	MicroRNAs in cardiomyocyte hypertrophy	0.0079999034350476	-4.8283258079942	102	11	0.0436507936507936	252	5358	5607,406911,406912,2932,8321,3084,5596,2263,9734,5291,5594	MAP2K5,MIR125B1,MIR125B2,GSK3B,FZD1,NRG1,MAPK4,FGFR2,HDAC9,PIK3CB,MAPK1
WP3915	Angiopoietin Like Protein 8 Regulatory Pathway	0.00874440682159265	-4.73934100339048	132	13	0.0515873015873016	252	5358	5594,868,5291,5602,5289,6197,5596,6885,6256,5288,5607,2932,53919	MAPK1,CBLB,PIK3CB,MAPK10,PIK3C3,RPS6KA3,MAPK4,MAP3K7,RXRA,PIK3C2G,MAP2K5,GSK3B,SLCO1C1
WP363	Wnt Signaling Pathway Netpath	0.0113235745308802	-4.48086848477319	53	7	0.0277777777777778	252	5358	7010,5594,53944,51701,2697,2932,6885	TEK,MAPK1,CSNK1G1,NLK,GJA1,GSK3B,MAP3K7
WP516	Hypertrophy Model	0.0127537581552339	-4.36192929353685	20	4	0.0158730158730159	252	5358	3475,8013,11072,2660	IFRD1,NR4A3,DUSP14,MSTN
WP2853	Endoderm Differentiation	0.0192492618559478	-3.95028256412911	146	13	0.0515873015873016	252	5358	6928,9241,154091,1488,5090,351,79668,6657,51701,3720,9425,58499,8320	HNF1B,NOG,SLC2A12,CTBP2,PBX3,APP,PARP8,SOX2,NLK,JARID2,CDYL,ZNF462,EOMES
WP2868	TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer	0.0200505134287629	-3.90950051813783	5	2	0.00793650793650794	252	5358	1956,5594	EGFR,MAPK1
WP24	Peptide GPCRs	0.0220106075978669	-3.81623077828791	74	8	0.0317460317460317	252	5358	7852,2925,552,7201,886,4887,4158,1909	CXCR4,GRPR,AVPR1A,TRHR,CCKAR,NPY2R,MC2R,EDNRA
WP399	Wnt Signaling Pathway and Pluripotency	0.0281480163498887	-3.57027839402364	107	10	0.0396825396825397	252	5358	5602,8321,5519,1488,2932,6885,51701,5587,6657,28227	MAPK10,FZD1,PPP2R1B,CTBP2,GSK3B,MAP3K7,NLK,PRKD1,SOX2,PPP2R3B
WP26	Signal Transduction of S1P Receptor	0.0315877197198417	-3.45498685038092	26	4	0.0158730158730159	252	5358	2770,5594,406974,5596	GNAI1,MAPK1,MIR197,MAPK4
WP501	GPCRs, Class C Metabotropic glutamate, pheromone	0.0365502154985314	-3.30906819681108	16	3	0.0119047619047619	252	5358	51704,9568,2911	GPRC5B,GABBR2,GRM1
WP2406	Cardiac Progenitor Differentiation	0.0367787565294819	-3.3028348687113	53	6	0.0238095238095238	252	5358	3791,7852,2932,3084,6657,9241	KDR,CXCR4,GSK3B,NRG1,SOX2,NOG
WP437	EGF/EGFR Signaling Pathway	0.0423375816155164	-3.16208013310426	163	13	0.0515873015873016	252	5358	1956,2697,5607,8202,4734,5596,7291,6197,6456,50807,868,5594,2059	EGFR,GJA1,MAP2K5,NCOA3,NEDD4,MAPK4,TWIST1,RPS6KA3,SH3GL2,ASAP1,CBLB,MAPK1,EPS8
WP2636	Common Pathways Underlying Drug Addiction	0.0454931264078897	-3.09019403239561	42	5	0.0198412698412698	252	5358	2911,2890,2770,5594,114	GRM1,GRIA1,GNAI1,MAPK1,ADCY8
WP1	Statin Pathway	0.0470324748043132	-3.05691696258714	1	1	0.00396825396825397	252	5358	1071	CETP
WP364	IL-6 signaling pathway	0.0495858486703797	-3.00404979502455	43	5	0.0198412698412698	252	5358	2932,6885,639,5594,51701	GSK3B,MAP3K7,PRDM1,MAPK1,NLK
WP3664	Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds	0.0497247661998547	-3.00125215611631	18	3	0.0119047619047619	252	5358	8321,2932,8658	FZD1,GSK3B,TNKS
WP3413	NOTCH1 regulation of human endothelial cell calcification	0.0497247661998547	-3.00125215611631	18	3	0.0119047619047619	252	5358	55553,102464826,1902	SOX6,MIR6073,LPAR1
WP716	Vitamin A and Carotenoid Metabolism	0.0538886318251072	-2.92083573564799	44	5	0.0198412698412698	252	5358	5594,5948,5915,5950,6256	MAPK1,RBP2,RARB,RBP4,RXRA
WP2583	T-Cell Receptor and Co-stimulatory Signaling	0.0554569496428651	-2.89214824133732	31	4	0.0158730158730159	252	5358	2534,1493,2932,3702	FYN,CTLA4,GSK3B,ITK
WP2879	Farnesoid X Receptor  Pathway	0.0570632544929356	-2.86359489849424	19	3	0.0119047619047619	252	5358	10891,5244,6256	PPARGC1A,ABCB4,RXRA
WP2572	Primary Focal Segmental Glomerulosclerosis FSGS	0.0578813701053377	-2.84935970601772	74	7	0.0277777777777778	252	5358	7402,5800,2195,1000,23607,5420,2534	UTRN,PTPRO,FAT1,CDH2,CD2AP,PODXL,FYN
WP2118	Arrhythmogenic Right Ventricular Cardiomyopathy	0.065052805530702	-2.73255594611887	76	7	0.0277777777777778	252	5358	6262,1000,3655,781,2697,6546,1829	RYR2,CDH2,ITGA6,CACNA2D1,GJA1,SLC8A1,DSG2
WP3863	T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection	0.0697539264935212	-2.66278156605118	62	6	0.0238095238095238	252	5358	5788,2534,3702,6885,2932,1493	PTPRC,FYN,ITK,MAP3K7,GSK3B,CTLA4
WP2197	Endothelin Pathways	0.0733734545684242	-2.61219306315553	34	4	0.0158730158730159	252	5358	2770,5594,1909,10203	GNAI1,MAPK1,EDNRA,CALCRL
WP481	Insulin Signaling	0.0754360243190211	-2.58447034195255	161	12	0.0476190476190476	252	5358	5594,868,5291,5602,6197,5289,5596,6885,2888,5288,5607,2932	MAPK1,CBLB,PIK3CB,MAPK10,RPS6KA3,PIK3C3,MAPK4,MAP3K7,GRB14,PIK3C2G,MAP2K5,GSK3B
WP1424	Globo Sphingolipid Metabolism	0.0818930668506665	-2.50234094554447	22	3	0.0119047619047619	252	5358	6480,6489,256435	ST6GAL1,ST8SIA1,ST6GALNAC3
WP3872	Regulation of Apoptosis by Parathyroid Hormone-related Protein	0.0818930668506665	-2.50234094554447	22	3	0.0119047619047619	252	5358	2932,79370,3655	GSK3B,BCL2L14,ITGA6
WP3599	Transcription factor regulation in adipogenesis	0.0818930668506665	-2.50234094554447	22	3	0.0119047619047619	252	5358	6256,10891,7291	RXRA,PPARGC1A,TWIST1
WP474	Endochondral Ossification	0.0836146464662014	-2.48153657727255	65	6	0.0238095238095238	252	5358	2737,7042,102464826,8817,6660,55553	GLI3,TGFB2,MIR6073,FGF18,SOX5,SOX6
WP500	Glycogen Metabolism	0.0867560856401572	-2.44465471114412	36	4	0.0158730158730159	252	5358	28227,2632,5519,2932	PPP2R3B,GBE1,PPP2R1B,GSK3B
WP2943	Hypoxia-mediated EMT and Stemness	0.0918612626216764	-2.38747585511389	2	1	0.00396825396825397	252	5358	23405	DICER1
WP3303	Rac1/Pak1/p38/MMP-2 pathway	0.0988926141765664	-2.3137207228533	68	6	0.0238095238095238	252	5358	1956,10413,284,2888,5594,7010	EGFR,YAP1,ANGPT1,GRB14,MAPK1,TEK
WP2064	Neural Crest Differentiation	0.105913985697205	-2.24512796996519	102	8	0.0317460317460317	252	5358	1488,1000,1005,6660,7291,2263,9734,2932	CTBP2,CDH2,CDH7,SOX5,TWIST1,FGFR2,HDAC9,GSK3B
WP117	GPCRs, Other	0.105913985697205	-2.24512796996519	102	8	0.0317460317460317	252	5358	128674,9287,2925,54112,2911,23284,11245,1909	PROKR2,TAAR2,GRPR,GPR88,GRM1,ADGRL3,GPR176,EDNRA
WP1559	TFs Regulate miRNAs related to cardiac hypertrophy	0.106630431839276	-2.23838633107489	12	2	0.00793650793650794	252	5358	406912,406911	MIR125B2,MIR125B1
WP1425	Bone Morphogenic Protein (BMP) Signalling and Regulation	0.106630431839276	-2.23838633107489	12	2	0.00793650793650794	252	5358	9241,658	NOG,BMPR1B
WP205	IL-7 Signaling Pathway	0.110539950713784	-2.20237827844483	25	3	0.0119047619047619	252	5358	2932,2534,5594	GSK3B,FYN,MAPK1
WP325	Triacylglyceride Synthesis	0.12083806780014	-2.11330391232884	26	3	0.0119047619047619	252	5358	56894,2710,8613	AGPAT3,GK,PLPP3
WP3679	Cell-type Dependent Selectivity of CCK2R Signaling	0.122253098524442	-2.10166180514515	13	2	0.00793650793650794	252	5358	2770,6262	GNAI1,RYR2
WP289	Myometrial Relaxation and Contraction Pathways	0.123424404448363	-2.0921264200596	158	11	0.0436507936507936	252	5358	57007,114,6262,108,800,5569,8787,2697,5587,1902,6546	ACKR3,ADCY8,RYR2,ADCY2,CALD1,PKIA,RGS9,GJA1,PRKD1,LPAR1,SLC8A1
WP229	Irinotecan Pathway	0.138386047196914	-1.97770805593194	14	2	0.00793650793650794	252	5358	590,9429	BCHE,ABCG2
WP2884	NRF2 pathway	0.143666959497554	-1.94025743928254	145	10	0.0396825396825397	252	5358	64116,154091,2042,56606,81031,3084,55117,131,6256,7042	SLC39A8,SLC2A12,EPHA3,SLC2A9,SLC2A10,NRG1,SLC6A15,ADH7,RXRA,TGFB2
WP2643	Nanoparticle-mediated activation of receptor signaling	0.153664041490421	-1.87298660837596	29	3	0.0119047619047619	252	5358	5594,1956,5602	MAPK1,EGFR,MAPK10
WP35	G Protein Signaling Pathways	0.158337086791925	-1.84302905784232	95	7	0.0277777777777778	252	5358	5587,5151,406974,108,114,2770,9590	PRKD1,PDE8A,MIR197,ADCY2,ADCY8,GNAI1,AKAP12
WP2870	Extracellular vesicle-mediated signaling in recipient cells	0.165173596401174	-1.80075825874919	30	3	0.0119047619047619	252	5358	7042,7043,1956	TGFB2,TGFB3,EGFR
WP3584	MECP2 and Associated Rett Syndrome	0.165404616177085	-1.79936058760978	62	5	0.0198412698412698	252	5358	9315,54790,2530,2890,7337	NREP,TET2,FUT8,GRIA1,UBE3A
WP536	Calcium Regulation in the Cardiac Cell	0.172226063279213	-1.75894734374221	151	10	0.0396825396825397	252	5358	2770,114,6262,406974,108,5569,8787,2697,5587,6546	GNAI1,ADCY8,RYR2,MIR197,ADCY2,PKIA,RGS9,GJA1,PRKD1,SLC8A1
WP382	MAPK Signaling Pathway	0.175505183130778	-1.74008670300361	170	11	0.0436507936507936	252	5358	51701,6197,7043,5596,6885,5594,5602,5607,1956,839,7042	NLK,RPS6KA3,TGFB3,MAPK4,MAP3K7,MAPK1,MAPK10,MAP2K5,EGFR,CASP6,TGFB2
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	0.176928951411413	-1.73200703144793	31	3	0.0119047619047619	252	5358	10891,2932,2660	PPARGC1A,GSK3B,MSTN
WP2112	IL17 signaling pathway	0.176928951411413	-1.73200703144793	31	3	0.0119047619047619	252	5358	2932,6885,5594	GSK3B,MAP3K7,MAPK1
WP554	ACE Inhibitor Pathway	0.189058197258286	-1.66570038931923	17	2	0.00793650793650794	252	5358	59272,10159	ACE2,ATP6AP2
WP3678	Amplification and Expansion of Oncogenic Pathways as Metastatic Traits	0.189058197258286	-1.66570038931923	17	2	0.00793650793650794	252	5358	7852,2034	CXCR4,EPAS1
WP2261	Signaling Pathways in Glioblastoma	0.194525706334556	-1.63719095841232	83	6	0.0238095238095238	252	5358	5291,5594,5288,1956,2263,5607	PIK3CB,MAPK1,PIK3C2G,EGFR,FGFR2,MAP2K5
WP2363	Gastric Cancer Network 2	0.201087557238798	-1.60401485761952	33	3	0.0119047619047619	252	5358	1956,29089,1297	EGFR,UBE2T,COL9A1
WP3859	TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition	0.206474876142607	-1.57757653915183	18	2	0.00793650793650794	252	5358	1000,5594	CDH2,MAPK1
WP2637	Structural Pathway of Interleukin 1 (IL-1)	0.207234415138042	-1.57390468616319	50	4	0.0158730158730159	252	5358	5594,5602,10010,6885	MAPK1,MAPK10,TANK,MAP3K7
WP3680	Association Between Physico-Chemical Features and Toxicity Associated Pathways	0.214567866299467	-1.53912919765127	68	5	0.0198412698412698	252	5358	1956,2890,5594,2932,8321	EGFR,GRIA1,MAPK1,GSK3B,FZD1
WP1992	TarBasePathway	0.224052713984145	-1.49587392452656	19	2	0.00793650793650794	252	5358	2697,2078	GJA1,ERG
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	0.224052713984145	-1.49587392452656	19	2	0.00793650793650794	252	5358	10891,19	PPARGC1A,ABCA1
WP384	Apoptosis Modulation by HSP70	0.224052713984145	-1.49587392452656	19	2	0.00793650793650794	252	5358	5602,839	MAPK10,CASP6
WP299	Nuclear Receptors in Lipid Metabolism and Toxicity	0.225964710071986	-1.48737644202651	35	3	0.0119047619047619	252	5358	5244,5915,19	ABCB4,RARB,ABCA1
WP2267	Synaptic Vesicle Pathway	0.227343248326046	-1.48129429642042	52	4	0.0158730158730159	252	5358	161,22999,6507,6857	AP2A2,RIMS1,SLC1A3,SYT1
WP2380	Brain-Derived Neurotrophic Factor (BDNF) signaling pathway	0.235773968901755	-1.44488169179151	144	9	0.0357142857142857	252	5358	6197,5607,2890,2932,4915,2534,5594,5602,1000	RPS6KA3,MAP2K5,GRIA1,GSK3B,NTRK2,FYN,MAPK1,MAPK10,CDH2
WP428	Wnt Signaling Pathway	0.240715986647459	-1.42413751908473	71	5	0.0198412698412698	252	5358	83999,5587,5602,2932,8321	KREMEN1,PRKD1,MAPK10,GSK3B,FZD1
WP673	ErbB Signaling Pathway	0.247922601011187	-1.39463867422504	54	4	0.0158730158730159	252	5358	3084,2932,5594,1956	NRG1,GSK3B,MAPK1,EGFR
WP455	GPCRs, Class A Rhodopsin-like	0.249777685397612	-1.38718401515426	262	15	0.0595238095238095	252	5358	886,2857,1909,57007,4158,7852,2861,7201,552,4887,56923,10886,3350,2925,151	CCKAR,GPR34,EDNRA,ACKR3,MC2R,CXCR4,GPR37,TRHR,AVPR1A,NPY2R,NMUR2,NPFFR2,HTR1A,GRPR,ADRA2B
WP1981	Thyroxine (Thyroid Hormone) Production	0.251126333341586	-1.38179914638742	6	1	0.00396825396825397	252	5358	7038	TG
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	0.251392866646722	-1.38073835774438	37	3	0.0119047619047619	252	5358	5160,284,7043	PDHA1,ANGPT1,TGFB3
WP1602	Nicotine Activity on Dopaminergic Neurons	0.259482794564624	-1.34906488083007	21	2	0.00793650793650794	252	5358	108,2770	ADCY2,GNAI1
WP69	T-Cell antigen Receptor (TCR)  Signaling Pathway	0.272093825763495	-1.301608324507	93	6	0.0238095238095238	252	5358	5594,2534,868,9308,6885,3702	MAPK1,FYN,CBLB,CD83,MAP3K7,ITK
WP170	Nuclear Receptors	0.277213701047025	-1.28296658631127	39	3	0.0119047619047619	252	5358	2099,5915,6256	ESR1,RARB,RXRA
WP1584	Type II diabetes mellitus	0.277241767339296	-1.28286534718966	22	2	0.00793650793650794	252	5358	5594,2710	MAPK1,GK
WP236	Adipogenesis	0.280861608559494	-1.26989322719405	132	8	0.0317460317460317	252	5358	6256,2034,8788,8321,2971,651,10891,7291	RXRA,EPAS1,DLK1,FZD1,GTF3A,BMP3,PPARGC1A,TWIST1
WP51	Regulation of Actin Cytoskeleton	0.285966497287735	-1.25188061737456	152	9	0.0357142857142857	252	5358	5594,9459,5291,8817,5288,2263,5289,1956,5596	MAPK1,ARHGEF6,PIK3CB,FGF18,PIK3C2G,FGFR2,PIK3C3,EGFR,MAPK4
WP528	Acetylcholine Synthesis	0.286387201052188	-1.25041053395782	7	1	0.00396825396825397	252	5358	5160	PDHA1
WP438	Non-homologous end joining	0.286387201052188	-1.25041053395782	7	1	0.00396825396825397	252	5358	7518	XRCC4
WP2805	RNA interference	0.286387201052188	-1.25041053395782	7	1	0.00396825396825397	252	5358	23405	DICER1
WP127	IL-5 Signaling Pathway	0.290224699478606	-1.23709983023586	40	3	0.0119047619047619	252	5358	2932,161742,5594	GSK3B,SPRED1,MAPK1
WP524	G13 Signaling Pathway	0.290224699478606	-1.23709983023586	40	3	0.0119047619047619	252	5358	5602,10788,5291	MAPK10,IQGAP2,PIK3CB
WP712	Estrogen signaling pathway	0.294974748896327	-1.22086552326755	23	2	0.00793650793650794	252	5358	5594,2099	MAPK1,ESR1
WP710	DNA Damage Response (only ATM dependent)	0.296299526361442	-1.21638442291405	115	7	0.0277777777777778	252	5358	2932,5602,6885,5288,5594,5289,5291	GSK3B,MAPK10,MAP3K7,PIK3C2G,MAPK1,PIK3C3,PIK3CB
WP304	Kit receptor signaling pathway	0.311644410000132	-1.16589245267578	60	4	0.0158730158730159	252	5358	4254,2534,5594,6197	KITLG,FYN,MAPK1,RPS6KA3
WP334	GPCRs, Class B Secretin-like	0.312645029702935	-1.16268682241509	24	2	0.00793650793650794	252	5358	23284,10203	ADGRL3,CALCRL
WP262	EBV LMP1 signaling	0.312645029702935	-1.16268682241509	24	2	0.00793650793650794	252	5358	5594,6885	MAPK1,MAP3K7
WP306	Focal Adhesion	0.315923902283266	-1.15225390995523	196	11	0.0436507936507936	252	5358	5596,2534,5594,5291,5607,1956,3655,1301,2932,53918,3791	MAPK4,FYN,MAPK1,PIK3CB,MAP2K5,EGFR,ITGA6,COL11A1,GSK3B,PELO,KDR
WP2036	TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway	0.316360499497486	-1.15087289444266	42	3	0.0119047619047619	252	5358	5594,2932,6885	MAPK1,GSK3B,MAP3K7
WP3407	FTO Obesity Variant Mechanism	0.319994083010465	-1.13945277395161	8	1	0.00396825396825397	252	5358	10891	PPARGC1A
WP3655	Hypothetical Craniofacial Development Pathway	0.319994083010465	-1.13945277395161	8	1	0.00396825396825397	252	5358	7043	TGFB3
WP2338	miRNA Biogenesis	0.319994083010465	-1.13945277395161	8	1	0.00396825396825397	252	5358	23405	DICER1
WP2485	NAD Biosynthesis II (from tryptophan)	0.319994083010465	-1.13945277395161	8	1	0.00396825396825397	252	5358	8942	KYNU
WP23	B Cell Receptor Signaling Pathway	0.321819669160598	-1.13376392397789	99	6	0.0238095238095238	252	5358	6885,2932,5596,5788,2534,5594	MAP3K7,GSK3B,MAPK4,PTPRC,FYN,MAPK1
WP2895	Differentiation of white and brown adipocyte	0.330219384395062	-1.10799804420688	25	2	0.00793650793650794	252	5358	10891,4093	PPARGC1A,SMAD9
WP3668	Hypothesized Pathways in Pathogenesis of Cardiovascular Disease	0.330219384395062	-1.10799804420688	25	2	0.00793650793650794	252	5358	2201,5594	FBN2,MAPK1
WP623	Oxidative phosphorylation	0.333278758353327	-1.09877602701252	62	4	0.0158730158730159	252	5358	4710,4724,518,10159	NDUFB4,NDUFS4,ATP5MC3,ATP6AP2
WP2431	Spinal Cord Injury	0.334541703126244	-1.09499373416174	120	7	0.0277777777777778	252	5358	1462,2043,2697,1956,900,9353,5594	VCAN,EPHA4,GJA1,EGFR,CCNG1,SLIT2,MAPK1
WP314	Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation	0.342539837736254	-1.07136731348546	44	3	0.0119047619047619	252	5358	6885,11124,839	MAP3K7,FAF1,CASP6
WP581	EPO Receptor Signaling	0.347667827445083	-1.05650777388683	26	2	0.00793650793650794	252	5358	5594,5788	MAPK1,PTPRC
WP3585	Cytosine methylation	0.352024268257055	-1.04405516184847	9	1	0.00396825396825397	252	5358	54790	TET2
WP288	NLR Proteins	0.352024268257055	-1.04405516184847	9	1	0.00396825396825397	252	5358	6885	MAP3K7
WP3674	Tgif disruption of Shh signaling	0.352024268257055	-1.04405516184847	9	1	0.00396825396825397	252	5358	2737	GLI3
WP3300	Dual hijack model of Vif in HIV infection	0.352024268257055	-1.04405516184847	9	1	0.00396825396825397	252	5358	861	RUNX1
WP706	Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways	0.352212686646036	-1.04352006242728	162	9	0.0357142857142857	252	5358	9734,55536,6507,4915,2697,10891,3350,6657,6262	HDAC9,CDCA7L,SLC1A3,NTRK2,GJA1,PPARGC1A,HTR1A,SOX2,RYR2
WP185	Integrin-mediated Cell Adhesion	0.364208039752203	-1.01003003683013	104	6	0.0238095238095238	252	5358	5602,2534,5594,5607,3655,5596	MAPK10,FYN,MAPK1,MAP2K5,ITGA6,MAPK4
WP2203	Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway	0.381631677962642	-0.963299329324502	47	3	0.0119047619047619	252	5358	7292,2534,5594	TNFSF4,FYN,MAPK1
WP268	Notch Signaling Pathway	0.381631677962642	-0.963299329324502	47	3	0.0119047619047619	252	5358	1840,83464,1488	DTX1,APH1B,CTBP2
WP3601	Composition of Lipid Particles	0.382551447991831	-0.960892130206666	10	1	0.00396825396825397	252	5358	1071	CETP
WP1531	Vitamin D Metabolism	0.382551447991831	-0.960892130206666	10	1	0.00396825396825397	252	5358	6256	RXRA
WP704	Methylation Pathways	0.382551447991831	-0.960892130206666	10	1	0.00396825396825397	252	5358	4837	NNMT
WP2874	Liver X Receptor Pathway	0.382551447991831	-0.960892130206666	10	1	0.00396825396825397	252	5358	6256	RXRA
WP2849	Hematopoietic Stem Cell Differentiation	0.394561642813572	-0.929979895355124	48	3	0.0119047619047619	252	5358	861,4254,7852	RUNX1,KITLG,CXCR4
WP2586	Aryl Hydrocarbon Receptor	0.394561642813572	-0.929979895355124	48	3	0.0119047619047619	252	5358	2099,1956,5594	ESR1,EGFR,MAPK1
WP2848	Differentiation Pathway	0.394561642813572	-0.929979895355124	48	3	0.0119047619047619	252	5358	9241,7043,4254	NOG,TGFB3,KITLG
WP2032	Human Thyroid Stimulating Hormone (TSH) signaling pathway	0.398334970774738	-0.920461992561524	68	4	0.0158730158730159	252	5358	406974,108,5594,2770	MIR197,ADCY2,MAPK1,GNAI1
WP422	MAPK Cascade	0.39900171397052	-0.918789566436036	29	2	0.00793650793650794	252	5358	5594,5602	MAPK1,MAPK10
WP2854	Gene regulatory network modelling somitogenesis	0.411645882377676	-0.887591808014134	11	1	0.00396825396825397	252	5358	2043	EPHA4
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	0.415703722369858	-0.877782478301626	30	2	0.00793650793650794	252	5358	2932,5291	GSK3B,PIK3CB
WP138	Androgen receptor signaling pathway	0.42736380798429	-0.850119619176541	91	5	0.0198412698412698	252	5358	8202,2932,2119,7337,1956	NCOA3,GSK3B,ETV5,UBE3A,EGFR
WP3925	Amino Acid metabolism	0.42736380798429	-0.850119619176541	91	5	0.0198412698412698	252	5358	50,6611,8050,131,5160	ACO2,SMS,PDHX,ADH7,PDHA1
WP366	TGF-beta Signaling Pathway	0.436023318694876	-0.830059553818152	133	7	0.0277777777777778	252	5358	5594,23327,351,10413,5596,4739,6885	MAPK1,NEDD4L,APP,YAP1,MAPK4,NEDD9,MAP3K7
WP1984	Integrated Breast Cancer Pathway	0.4387235126163	-0.82388587612971	154	8	0.0317460317460317	252	5358	5569,56911,5594,2099,8202,23077,1956,4664	PKIA,MAP3K7CL,MAPK1,ESR1,NCOA3,MYCBP2,EGFR,NAB1
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	0.439374559702411	-0.822403018517486	12	1	0.00396825396825397	252	5358	5594	MAPK1
WP3849	MAPK  and NFkB Signalling Pathways Inhibited by Yersinia YopJ	0.439374559702411	-0.822403018517486	12	1	0.00396825396825397	252	5358	5594	MAPK1
WP2007	Iron metabolism in placenta	0.439374559702411	-0.822403018517486	12	1	0.00396825396825397	252	5358	30061	SLC40A1
WP2828	Bladder Cancer	0.448388501505138	-0.802095231500221	32	2	0.00793650793650794	252	5358	5594,1956	MAPK1,EGFR
WP3893	Development and heterogeneity of the ILC family	0.448388501505138	-0.802095231500221	32	2	0.00793650793650794	252	5358	8320,2672	EOMES,GFI1
WP34	Ovarian Infertility Genes	0.448388501505138	-0.802095231500221	32	2	0.00793650793650794	252	5358	658,23224	BMPR1B,SYNE2
WP2875	Constitutive Androstane Receptor Pathway	0.448388501505138	-0.802095231500221	32	2	0.00793650793650794	252	5358	6256,10891	RXRA,PPARGC1A
WP2377	Integrated Pancreatic Cancer Pathway	0.4488803184042	-0.800998978209338	197	10	0.0396825396825397	252	5358	1956,7486,5596,1630,5594,2099,351,6256,6240,5915	EGFR,WRN,MAPK4,DCC,MAPK1,ESR1,APP,RXRA,RRM1,RARB
WP1533	Vitamin B12 Metabolism	0.45794242234734	-0.781011818169615	53	3	0.0119047619047619	252	5358	19,4552,8029	ABCA1,MTRR,CUBN
WP3676	BDNF-TrkB Signaling	0.464343401129562	-0.767130911845134	33	2	0.00793650793650794	252	5358	4915,5594	NTRK2,MAPK1
WP430	Statin Pathway	0.464343401129562	-0.767130911845134	33	2	0.00793650793650794	252	5358	19,1071	ABCA1,CETP
WP2881	Estrogen Receptor Pathway	0.465801348137642	-0.76399602729469	13	1	0.00396825396825397	252	5358	2099	ESR1
WP1434	Osteopontin Signaling	0.465801348137642	-0.76399602729469	13	1	0.00396825396825397	252	5358	5594	MAPK1
WP1423	Ganglio Sphingolipid Metabolism	0.465801348137642	-0.76399602729469	13	1	0.00396825396825397	252	5358	6489	ST8SIA1
WP1991	SRF and miRs in Smooth Muscle Differentiation and Proliferation	0.465801348137642	-0.76399602729469	13	1	0.00396825396825397	252	5358	9314	KLF4
WP3876	BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation	0.465801348137642	-0.76399602729469	13	1	0.00396825396825397	252	5358	4093	SMAD9
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	0.470296529485317	-0.754391869421924	54	3	0.0119047619047619	252	5358	3084,351,5594	NRG1,APP,MAPK1
WP3286	Copper homeostasis	0.470296529485317	-0.754391869421924	54	3	0.0119047619047619	252	5358	1317,2932,351	SLC31A1,GSK3B,APP
WP400	p38 MAPK Signaling Pathway	0.480024427047692	-0.733918286692345	34	2	0.00793650793650794	252	5358	6885,7042	MAP3K7,TGFB2
WP58	Monoamine GPCRs	0.480024427047692	-0.733918286692345	34	2	0.00793650793650794	252	5358	3350,151	HTR1A,ADRA2B
WP1601	Fluoropyrimidine Activity	0.480024427047692	-0.733918286692345	34	2	0.00793650793650794	252	5358	6240,9429	RRM1,ABCG2
WP2037	Prolactin Signaling Pathway	0.483120546300707	-0.727489078206705	76	4	0.0158730158730159	252	5358	5594,2534,5291,2932	MAPK1,FYN,PIK3CB,GSK3B
WP2034	Leptin signaling pathway	0.483120546300707	-0.727489078206705	76	4	0.0158730158730159	252	5358	2099,5594,2534,2932	ESR1,MAPK1,FYN,GSK3B
WP244	Alpha 6 Beta 4 signaling pathway	0.495421985652471	-0.702345383314387	35	2	0.00793650793650794	252	5358	5594,3655	MAPK1,ITGA6
WP195	IL-1 signaling pathway	0.506567655628667	-0.680097389428588	57	3	0.0119047619047619	252	5358	5594,57161,6885	MAPK1,PELI2,MAP3K7
WP3	Transcriptional activation by NRF2	0.51498999242122	-0.663607810699015	15	1	0.00396825396825397	252	5358	4094	MAF
WP206	Fatty Acid Omega Oxidation	0.51498999242122	-0.663607810699015	15	1	0.00396825396825397	252	5358	131	ADH7
WP1449	Regulation of toll-like receptor signaling pathway	0.527772236433985	-0.639090458733027	145	7	0.0277777777777778	252	5358	406891,57161,5594,5291,4064,6885,5602	MIRLET7I,PELI2,MAPK1,PIK3CB,CD180,MAP3K7,MAPK10
WP47	Hedgehog Signaling Pathway	0.537865253869307	-0.620147207682063	16	1	0.00396825396825397	252	5358	2737	GLI3
WP2453	TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc)	0.537865253869307	-0.620147207682063	16	1	0.00396825396825397	252	5358	5160	PDHA1
WP3865	RIG-I-like Receptor Signaling	0.552848306138752	-0.592671625869719	61	3	0.0119047619047619	252	5358	5602,10010,6885	MAPK10,TANK,MAP3K7
WP78	TCA Cycle	0.559665694902803	-0.580415646900355	17	1	0.00396825396825397	252	5358	50	ACO2
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	0.559665694902803	-0.580415646900355	17	1	0.00396825396825397	252	5358	3720	JARID2
WP615	Senescence and Autophagy in Cancer	0.562827867135898	-0.574781439800898	106	5	0.0198412698412698	252	5358	9966,5594,5289,2932,7405	TNFSF15,MAPK1,PIK3C3,GSK3B,UVRAG
WP61	Notch Signaling Pathway	0.575007147645201	-0.553372807574741	63	3	0.0119047619047619	252	5358	83464,2932,1840	APH1B,GSK3B,DTX1
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	0.580441625426309	-0.543966042028405	18	1	0.00396825396825397	252	5358	5594	MAPK1
WP692	Sulfation Biotransformation Reaction	0.580441625426309	-0.543966042028405	18	1	0.00396825396825397	252	5358	9061	PAPSS1
WP49	IL-2 Signaling Pathway	0.594748407677978	-0.519616807099033	42	2	0.00793650793650794	252	5358	5594,2534	MAPK1,FYN
WP466	DNA Replication	0.594748407677978	-0.519616807099033	42	2	0.00793650793650794	252	5358	4999,6119	ORC2,RPA3
WP22	IL-9 Signaling Pathway	0.60024100939475	-0.510424022094155	19	1	0.00396825396825397	252	5358	5594	MAPK1
WP404	Nucleotide Metabolism	0.60024100939475	-0.510424022094155	19	1	0.00396825396825397	252	5358	6240	RRM1
WP734	Serotonin Receptor 4/6/7 and NR3C Signaling	0.60024100939475	-0.510424022094155	19	1	0.00396825396825397	252	5358	5594	MAPK1
WP247	Small Ligand GPCRs	0.60024100939475	-0.510424022094155	19	1	0.00396825396825397	252	5358	1902	LPAR1
WP2324	AGE/RAGE pathway	0.606938182156143	-0.499328334696749	66	3	0.0119047619047619	252	5358	4481,1956,5594	MSR1,EGFR,MAPK1
WP497	Urea cycle and metabolism of amino groups	0.619109573843259	-0.479473004445912	20	1	0.00396825396825397	252	5358	6611	SMS
WP732	Serotonin Receptor 2 and ELK-SRF/GATA4 signaling	0.619109573843259	-0.479473004445912	20	1	0.00396825396825397	252	5358	5594	MAPK1
WP391	Mitochondrial Gene Expression	0.619109573843259	-0.479473004445912	20	1	0.00396825396825397	252	5358	10891	PPARGC1A
WP2332	Interleukin-11 Signaling Pathway	0.620315854963377	-0.477526487175962	44	2	0.00793650793650794	252	5358	2534,5594	FYN,MAPK1
WP2533	Glycerophospholipid Biosynthetic Pathway	0.637090912811174	-0.450842913324824	21	1	0.00396825396825397	252	5358	2710	GK
WP2507	Nanomaterial induced apoptosis	0.637090912811174	-0.450842913324824	21	1	0.00396825396825397	252	5358	839	CASP6
WP176	Folate Metabolism	0.637244434711292	-0.450601969053507	69	3	0.0119047619047619	252	5358	55312,19,4552	RFK,ABCA1,MTRR
WP2355	Corticotropin-releasing hormone signaling pathway	0.643917425036214	-0.440184783092383	93	4	0.0158730158730159	252	5358	2770,5594,2697,2932	GNAI1,MAPK1,GJA1,GSK3B
WP465	Tryptophan metabolism	0.644627163070565	-0.439083171067968	46	2	0.00793650793650794	252	5358	8942,7337	KYNU,UBE3A
WP3645	NAD+ biosynthetic pathways	0.654226586413713	-0.42430152512289	22	1	0.00396825396825397	252	5358	8658	TNKS
WP2359	Parkin-Ubiquitin Proteasomal System pathway	0.656526725341131	-0.420791877246648	71	3	0.0119047619047619	252	5358	5413,2861,3308	SEPTIN5,GPR37,HSPA4
WP231	TNF alpha Signaling Pathway	0.660540686920941	-0.414696556733865	95	4	0.0158730158730159	252	5358	10010,6885,55312,5594	TANK,MAP3K7,RFK,MAPK1
WP2873	Aryl Hydrocarbon Receptor Pathway	0.667696469051719	-0.403921596357969	48	2	0.00793650793650794	252	5358	1956,10486	EGFR,CAP2
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	0.670556215387758	-0.399647738778954	23	1	0.00396825396825397	252	5358	9429	ABCG2
WP286	IL-3 Signaling Pathway	0.678772016768182	-0.387469971032543	49	2	0.00793650793650794	252	5358	2534,5594	FYN,MAPK1
WP410	Diurnally Regulated Genes with Circadian Orthologs	0.678772016768182	-0.387469971032543	49	2	0.00793650793650794	252	5358	9218,26059	VAPA,ERC2
WP534	Glycolysis and Gluconeogenesis	0.678772016768182	-0.387469971032543	49	2	0.00793650793650794	252	5358	8050,5160	PDHX,PDHA1
WP2509	Nanoparticle triggered autophagic cell death	0.68611757129424	-0.376706279214981	24	1	0.00396825396825397	252	5358	7405	UVRAG
WP3658	Wnt/beta-catenin Signaling Pathway in Leukemia	0.68611757129424	-0.376706279214981	24	1	0.00396825396825397	252	5358	2932	GSK3B
WP1528	Physiological and Pathological Hypertrophy  of the Heart	0.700946662409811	-0.355323482702845	25	1	0.00396825396825397	252	5358	5594	MAPK1
WP2059	Alzheimers Disease	0.710047560453171	-0.342423324636513	149	6	0.0238095238095238	252	5358	574441,407024,5594,406911,351,2932	MIR488,MIR29B1,MAPK1,MIR125B1,APP,GSK3B
WP2878	PPAR Alpha Pathway	0.715077815811691	-0.33536390890698	26	1	0.00396825396825397	252	5358	6256	RXRA
WP75	Toll-like Receptor Signaling Pathway	0.721707000662499	-0.326136038711938	103	4	0.0158730158730159	252	5358	5291,5594,5602,6885	PIK3CB,MAPK1,MAPK10,MAP3K7
WP2035	Follicle Stimulating Hormone (FSH) signaling pathway	0.728543755498758	-0.316707592695156	27	1	0.00396825396825397	252	5358	5594	MAPK1
WP3845	Canonical  and Non-canonical Notch signaling	0.728543755498758	-0.316707592695156	27	1	0.00396825396825397	252	5358	8788	DLK1
WP179	Cell Cycle	0.735660849949308	-0.3069860681543	105	4	0.0158730158730159	252	5358	4085,2932,4254,4999	MAD2L1,GSK3B,KITLG,ORC2
WP111	Electron Transport Chain	0.735660849949308	-0.3069860681543	105	4	0.0158730158730159	252	5358	4710,4724,518,1345	NDUFB4,NDUFS4,ATP5MC3,COX6C
WP585	Interferon type I signaling pathways	0.739031845521115	-0.302414266240999	55	2	0.00793650793650794	252	5358	5788,2534	PTPRC,FYN
WP2018	RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway	0.739031845521115	-0.302414266240999	55	2	0.00793650793650794	252	5358	5594,6885	MAPK1,MAP3K7
WP2249	Metastatic brain tumor	0.741375677022123	-0.299247795625723	28	1	0.00396825396825397	252	5358	407024	MIR29B1
WP3613	Photodynamic therapy-induced unfolded protein response	0.753603318554323	-0.282889152127871	29	1	0.00396825396825397	252	5358	7324	UBE2E1
WP2371	Parkinsons Disease Pathway	0.763901336919403	-0.269316638312774	84	3	0.0119047619047619	252	5358	839,2861,5413	CASP6,GPR37,SEPTIN5
WP2855	Dopaminergic Neurogenesis	0.765255028771776	-0.267546129767849	30	1	0.00396825396825397	252	5358	6657	SOX2
WP98	Prostaglandin Synthesis and Regulation	0.765255028771776	-0.267546129767849	30	1	0.00396825396825397	252	5358	1909	EDNRA
WP241	One Carbon Metabolism	0.765255028771776	-0.267546129767849	30	1	0.00396825396825397	252	5358	4552	MTRR
WP3851	TLR4 Signaling and Tolerance	0.765255028771776	-0.267546129767849	30	1	0.00396825396825397	252	5358	6885	MAP3K7
WP2361	Gastric Cancer Network 1	0.765255028771776	-0.267546129767849	30	1	0.00396825396825397	252	5358	8607	RUVBL1
WP560	TGF-beta Receptor Signaling	0.765384370884018	-0.267377125739103	58	2	0.00793650793650794	252	5358	9241,4093	NOG,SMAD9
WP3594	Circadian rythm related genes	0.766643728563097	-0.265733085446122	207	8	0.0317460317460317	252	5358	128674,2932,4887,5602,10891,6928,7337,90134	PROKR2,GSK3B,NPY2R,MAPK10,PPARGC1A,HNF1B,UBE3A,KCNH7
WP408	Oxidative Stress	0.776357831465761	-0.25314174206058	31	1	0.00396825396825397	252	5358	5602	MAPK10
WP254	Apoptosis	0.777749198839432	-0.251351173305297	86	3	0.0119047619047619	252	5358	5602,839,9169	MAPK10,CASP6,SCAF11
WP3527	Preimplantation Embryo	0.781646973941746	-0.246352080338721	60	2	0.00793650793650794	252	5358	9314,6657	KLF4,SOX2
WP3858	Toll-like Receptor Signaling	0.786937487270828	-0.239606465395799	32	1	0.00396825396825397	252	5358	5594	MAPK1
WP2446	Retinoblastoma (RB) in Cancer	0.790925683698492	-0.234551267968999	88	3	0.0119047619047619	252	5358	6119,6240,11124	RPA3,RRM1,FAF1
WP15	Selenium Micronutrient Network	0.797267900917013	-0.226564520014455	89	3	0.0119047619047619	252	5358	19,55312,8942	ABCA1,RFK,KYNU
WP313	Signaling of Hepatocyte Growth Factor Receptor	0.806624435053033	-0.214897103110035	34	1	0.00396825396825397	252	5358	5594	MAPK1
WP143	Fatty Acid Beta Oxidation	0.806624435053033	-0.214897103110035	34	1	0.00396825396825397	252	5358	2710	GK
WP2012	miRs in Muscle Cell Differentiation	0.824498861579741	-0.192979517723593	36	1	0.00396825396825397	252	5358	5587	PRKD1
WP3651	Pathways Affected in Adenoid Cystic Carcinoma	0.824650772138775	-0.192795288765398	66	2	0.00793650793650794	252	5358	4781,221037	NFIB,JMJD1C
WP1772	Apoptosis Modulation and Signaling	0.826617232962426	-0.190413529115016	94	3	0.0119047619047619	252	5358	839,5587,5783	CASP6,PRKD1,PTPN13
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	0.832808949305144	-0.182951015695476	37	1	0.00396825396825397	252	5358	9734	HDAC9
WP3298	Melatonin metabolism and effects	0.832808949305144	-0.182951015695476	37	1	0.00396825396825397	252	5358	2932	GSK3B
WP619	Type II interferon signaling (IFNG)	0.832808949305144	-0.182951015695476	37	1	0.00396825396825397	252	5358	3459	IFNGR1
WP3529	Zinc homeostasis	0.832808949305144	-0.182951015695476	37	1	0.00396825396825397	252	5358	64116	SLC39A8
WP1403	AMP-activated Protein Kinase (AMPK) Signaling	0.837206113253469	-0.177684986414175	68	2	0.00793650793650794	252	5358	5289,5291	PIK3C3,PIK3CB
WP45	G1 to S cell cycle control	0.837206113253469	-0.177684986414175	68	2	0.00793650793650794	252	5358	4999,6119	ORC2,RPA3
WP2447	Amyotrophic lateral sclerosis (ALS)	0.840727037030025	-0.173488241217623	38	1	0.00396825396825397	252	5358	2890	GRIA1
WP2526	PDGF Pathway	0.848271545809366	-0.164554475334614	39	1	0.00396825396825397	252	5358	5594	MAPK1
WP1433	Nucleotide-binding Oligomerization Domain (NOD) pathway	0.862309239178068	-0.148141326506206	41	1	0.00396825396825397	252	5358	639	PRDM1
WP405	Eukaryotic Transcription Initiation	0.868835113109958	-0.140601914976939	42	1	0.00396825396825397	252	5358	55703	POLR3B
WP2911	miRNA targets in ECM and membrane receptors	0.875052861701429	-0.133470981076275	43	1	0.00396825396825397	252	5358	693124	MIR532
WP1591	Heart Development	0.89199892346952	-0.114290353275591	46	1	0.00396825396825397	252	5358	5594	MAPK1
WP3646	Hepatitis C and Hepatocellular Carcinoma	0.915306594475875	-0.0884961939020999	51	1	0.00396825396825397	252	5358	5420	PODXL
WP3611	Photodynamic therapy-induced AP-1 survival signaling.	0.915306594475875	-0.0884961939020999	51	1	0.00396825396825397	252	5358	1956	EGFR
WP107	Translation Factors	0.923159592304595	-0.0799531533536664	53	1	0.00396825396825397	252	5358	1968	EIF2S3
WP702	Metapathway biotransformation	0.92585236911837	-0.0770404856439197	177	5	0.0198412698412698	252	5358	64579,340665,83539,4837,9957	NDST4,CYP26C1,CHST9,NNMT,HS3ST1
WP395	IL-4 Signaling Pathway	0.930287060271778	-0.07226207350378	55	1	0.00396825396825397	252	5358	5594	MAPK1
WP477	Cytoplasmic Ribosomal Proteins	0.930367656107464	-0.0721754418090036	90	2	0.00793650793650794	252	5358	6197,6235	RPS6KA3,RPS29
WP2272	Pathogenic Escherichia coli infection	0.933599838092212	-0.0687073714328862	56	1	0.00396825396825397	252	5358	2534	FYN
WP43	Oxidation by Cytochrome P450	0.952788824655506	-0.0483619899608122	63	1	0.00396825396825397	252	5358	340665	CYP26C1
WP2374	Oncostatin M Signaling Pathway	0.959214900692775	-0.041640140889101	66	1	0.00396825396825397	252	5358	5594	MAPK1
WP183	Proteasome Degradation	0.959214900692775	-0.041640140889101	66	1	0.00396825396825397	252	5358	4734	NEDD4
WP1982	Sterol Regulatory Element-Binding Proteins (SREBP) signalling	0.971020546680519	-0.0294076505845967	73	1	0.00396825396825397	252	5358	5950	RBP4
WP2328	Allograft Rejection	0.979418487681576	-0.0207962633538153	80	1	0.00396825396825397	252	5358	1493	CTLA4
WP411	mRNA Processing	0.988734462130811	-0.0113294746828541	134	2	0.00793650793650794	252	5358	10659,23405	CELF2,DICER1
WP1530	miRNA Regulation of DNA Damage Response	0.989112072036073	-0.010947635239473	93	1	0.00396825396825397	252	5358	900	CCNG1
WP3408	Evolocumab Mechanism	0.999999999993334	-6.6659659698565e-12	3	0	0	252	5358
WP2866	mir34a and TGIF2 in osteoclastogenesis	0.999999999993334	-6.6659659698565e-12	3	0	0	252	5358
WP2846	Proprotein convertase subtilisin/kexin type 9 (PCSK9) mediated LDL receptor degradation	0.999999999993334	-6.6659659698565e-12	3	0	0	252	5358
WP2513	Nanoparticle triggered regulated necrosis	0.99999999999354	-6.45990439303187e-12	11	0	0	252	5358
WP3630	NAD metabolism, sirtuins and aging	0.99999999999354	-6.45990439303187e-12	11	0	0	252	5358
WP1455	Serotonin Transporter Activity	0.99999999999354	-6.45990439303187e-12	11	0	0	252	5358
WP80	Nucleotide GPCRs	0.99999999999354	-6.45990439303187e-12	11	0	0	252	5358
WP1742	TP53 Network	0.999999999993844	-6.15625516583722e-12	20	0	0	252	5358
WP1422	Sphingolipid Metabolism	0.999999999993844	-6.15625516583722e-12	20	0	0	252	5358
WP1600	Nicotine Metabolism	0.999999999994315	-5.68529072038427e-12	6	0	0	252	5358
WP3891	Benzene metabolism	0.999999999994315	-5.68529072038427e-12	6	0	0	252	5358
WP694	Arylamine metabolism	0.999999999994315	-5.68529072038427e-12	6	0	0	252	5358
WP1311	Folic Acid Network	0.999999999994505	-5.49505016142482e-12	2	0	0	252	5358
WP2816	Felbamate Metabolism	0.999999999994505	-5.49505016142482e-12	2	0	0	252	5358
WP2646	Lidocaine metabolism	0.999999999994505	-5.49505016142482e-12	2	0	0	252	5358
WP2366	Butyrate-induced histone acetylation	0.999999999994505	-5.49505016142482e-12	2	0	0	252	5358
WP2901	Gonadotropin-releasing hormone (GnRH) signaling	0.999999999994505	-5.49505016142482e-12	2	0	0	252	5358
WP1438	Influenza A virus infection	0.999999999994505	-5.49505016142482e-12	2	0	0	252	5358
WP1273	Folic Acid Network	0.999999999994505	-5.49505016142482e-12	2	0	0	252	5358
WP2289	Drug Induction of Bile Acid Pathway	0.999999999994949	-5.05070955430987e-12	17	0	0	252	5358
WP3874	Canonical and Non-Canonical TGF-B signaling	0.999999999994949	-5.05070955430987e-12	17	0	0	252	5358
WP368	Mitochondrial LC-Fatty Acid Beta-Oxidation	0.999999999994949	-5.05070955430987e-12	17	0	0	252	5358
WP531	Mismatch repair	0.999999999998907	-1.0926343903473e-12	9	0	0	252	5358
WP561	Heme Biosynthesis	0.999999999998907	-1.0926343903473e-12	9	0	0	252	5358
WP3593	miR-148a/miR-31/FIH1/HIF1&alpha;-Notch signaling in glioblastoma	0.999999999998907	-1.0926343903473e-12	9	0	0	252	5358
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	0.999999999998907	-1.0926343903473e-12	9	0	0	252	5358
WP3875	ATR Signaling	0.999999999998907	-1.0926343903473e-12	9	0	0	252	5358
WP696	Benzo(a)pyrene metabolism	0.999999999998907	-1.0926343903473e-12	9	0	0	252	5358
WP3297	EV release from cardiac cells and their functional effects	0.999999999998907	-1.0926343903473e-12	9	0	0	252	5358
WP3633	Caffeine and Theobromine metabolism	0.999999999999414	-5.85675366372523e-13	4	0	0	252	5358
WP2491	Diclofenac Metabolic Pathway	0.999999999999414	-5.85675366372523e-13	4	0	0	252	5358
WP521	Amino acid conjugation of benzoic acid	0.999999999999414	-5.85675366372523e-13	4	0	0	252	5358
WP2253	Pilocytic astrocytoma	0.999999999999414	-5.85675366372523e-13	4	0	0	252	5358
WP1133	Androgen receptor signaling pathway	0.999999999999414	-5.85675366372523e-13	4	0	0	252	5358
WP1603	Nicotine Activity on Chromaffin Cells	0.999999999999414	-5.85675366372523e-13	4	0	0	252	5358
WP897	Androgen receptor signaling pathway	0.999999999999414	-5.85675366372523e-13	4	0	0	252	5358
WP733	Serotonin Receptor 2 and STAT3 Signaling	0.999999999999414	-5.85675366372523e-13	4	0	0	252	5358
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	0.999999999999414	-5.85675366372523e-13	4	0	0	252	5358
WP2889	Oxytocin signaling	0.999999999999414	-5.85675366372523e-13	4	0	0	252	5358
WP690	Polyol Pathway	0.999999999999414	-5.85675366372523e-13	4	0	0	252	5358
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	0.999999999999414	-5.85675366372523e-13	4	0	0	252	5358
WP3670	Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway	1.00000000000062	6.20942283428138e-13	21	0	0	252	5358
WP691	Tamoxifen metabolism	1.00000000000062	6.20942283428138e-13	21	0	0	252	5358
WP197	Cholesterol Biosynthesis	1.00000000000086	8.64482372085113e-13	15	0	0	252	5358
WP3644	NAD+ metabolism	1.00000000000088	8.83800606687142e-13	16	0	0	252	5358
WP550	Biogenic Amine Synthesis	1.00000000000088	8.83800606687142e-13	16	0	0	252	5358
WP53	ID signaling pathway	1.00000000000088	8.83800606687142e-13	16	0	0	252	5358
WP1946	Cori Cycle	1.00000000000088	8.83800606687142e-13	16	0	0	252	5358
WP12	Osteoclast Signaling	1.00000000000088	8.83800606687142e-13	16	0	0	252	5358
WP2291	Deregulation of Rab and Rab Effector Genes in Bladder Cancer	1.00000000000088	8.83800606687142e-13	16	0	0	252	5358
WP2435	Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis	1.00000000000088	8.83800606687142e-13	16	0	0	252	5358
WP3672	LncRNA-mediated mechanisms of therapeutic resistance	1.00000000000107	1.06979139996542e-12	12	0	0	252	5358
WP106	Alanine and aspartate metabolism	1.00000000000107	1.06979139996542e-12	12	0	0	252	5358
WP2290	RalA downstream regulated genes	1.00000000000107	1.06979139996542e-12	12	0	0	252	5358
WP3924	Hfe effect on hepcidin production	1.00000000000216	2.16046792675694e-12	7	0	0	252	5358
WP2596	Gastric acid production	1.00000000000216	2.16046792675694e-12	7	0	0	252	5358
WP1272	Selenium Micronutrient Network	1.00000000000216	2.16046792675694e-12	7	0	0	252	5358
WP678	Arachidonate Epoxygenase / Epoxide Hydrolase	1.00000000000216	2.16046792675694e-12	7	0	0	252	5358
WP3595	mir-124 predicted interactions with cell cycle and differentiation	1.00000000000216	2.16046792675694e-12	7	0	0	252	5358
WP699	Aflatoxin B1 metabolism	1.00000000000216	2.16046792675694e-12	7	0	0	252	5358
WP1310	Selenium Micronutrient Network	1.00000000000216	2.16046792675694e-12	7	0	0	252	5358
WP134	Pentose Phosphate Pathway	1.00000000000216	2.16046792675694e-12	7	0	0	252	5358
WP3596	miR-517 relationship with ARCN1 and USP1	1.00000000000241	2.41433206086575e-12	5	0	0	252	5358
WP311	Synthesis and Degradation of Ketone Bodies	1.00000000000241	2.41433206086575e-12	5	0	0	252	5358
WP2542	Sulindac Metabolic Pathway	1.00000000000241	2.41433206086575e-12	5	0	0	252	5358
WP688	Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs)	1.00000000000241	2.41433206086575e-12	5	0	0	252	5358
WP2597	Secretion of Hydrochloric Acid in Parietal Cells	1.00000000000241	2.41433206086575e-12	5	0	0	252	5358
WP2113	Type III interferon signaling	1.00000000000249	2.489907096383e-12	10	0	0	252	5358
WP2333	Trans-sulfuration pathway	1.00000000000249	2.489907096383e-12	10	0	0	252	5358
WP496	Steroid Biosynthesis	1.00000000000249	2.489907096383e-12	10	0	0	252	5358
WP3656	Interleukin-1 Induced Activation of NF-kappa-B	1.00000000000249	2.489907096383e-12	10	0	0	252	5358
WP237	Glucocorticoid &amp; Mineralcorticoid Metabolism	1.00000000000258	2.58012939349914e-12	8	0	0	252	5358
WP136	Phase I biotransformations, non P450	1.00000000000258	2.58012939349914e-12	8	0	0	252	5358
WP3635	Insulin signalling in human adipocytes (diabetic condition)	1.00000000000258	2.58012939349914e-12	8	0	0	252	5358
WP1589	Folate-Alcohol and Cancer Pathway	1.00000000000258	2.58012939349914e-12	8	0	0	252	5358
WP2276	Glial Cell Differentiation	1.00000000000258	2.58012939349914e-12	8	0	0	252	5358
WP3634	Insulin signalling in human adipocytes (normal condition)	1.00000000000258	2.58012939349914e-12	8	0	0	252	5358
WP1995	Effects of Nitric Oxide	1.00000000000258	2.58012939349914e-12	8	0	0	252	5358
WP1604	Codeine and Morphine Metabolism	1.00000000000258	2.58012939349914e-12	8	0	0	252	5358
WP322	Osteoblast Signaling	1.00000000000447	4.47226842104587e-12	14	0	0	252	5358
WP2436	Dopamine metabolism	1.00000000000447	4.47226842104587e-12	14	0	0	252	5358
WP661	Glucose Homeostasis	1.00000000000464	4.63818566887042e-12	1	0	0	252	5358
WP2536	Colchicine Metabolic Pathway	1.00000000000464	4.63818566887042e-12	1	0	0	252	5358
WP222	Cytokines and Inflammatory Response	1.00000000000464	4.63818566887042e-12	1	0	0	252	5358
WP3191	TSLP Signaling Pathway	1.00000000000464	4.63818566887042e-12	1	0	0	252	5358
WP188	Focal Adhesion	1.00000000000464	4.63818566887042e-12	1	0	0	252	5358
WP3627	Gut-Liver Indole Metabolism	1.00000000000464	4.63818566887042e-12	1	0	0	252	5358
WP108	Selenium metabolism/Selenoproteins	1.00000000000464	4.63818566887042e-12	1	0	0	252	5358
WP2190	One carbon donor	1.00000000000464	4.63818566887042e-12	1	0	0	252	5358
WP453	Inflammatory Response Pathway	1.00000000000532	5.3218435119514e-12	33	0	0	252	5358
WP3287	Overview of nanoparticle effects	1.0000000000056	5.59946250948462e-12	19	0	0	252	5358
WP697	Estrogen metabolism	1.0000000000056	5.59946250948462e-12	19	0	0	252	5358
WP3877	Simplified Depiction of MYD88 Distinct Input-Output Pathway	1.0000000000056	5.59946250948462e-12	19	0	0	252	5358
WP3871	Valproic acid pathway	1.00000000000899	8.98834063231227e-12	13	0	0	252	5358
WP3892	Development of pulmonary dendritic cells and macrophage subsets	1.00000000000899	8.98834063231227e-12	13	0	0	252	5358
WP186	Homologous recombination	1.00000000000899	8.98834063231227e-12	13	0	0	252	5358
WP2865	IL1 and megakaryocytes in obesity	1.00000000000948	9.48365972526993e-12	25	0	0	252	5358
WP272	Blood Clotting Cascade	1.00000000000985	9.84803995972275e-12	22	0	0	252	5358
WP357	Fatty Acid Biosynthesis	1.00000000000985	9.84803995972275e-12	22	0	0	252	5358
WP545	Complement Activation	1.00000000000985	9.84803995972275e-12	22	0	0	252	5358
WP3657	Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex	1.00000000000985	9.84803995972275e-12	22	0	0	252	5358
WP530	Cytokines and Inflammatory Response	1.00000000001027	1.02719298966406e-11	29	0	0	252	5358
WP698	Glucuronidation	1.00000000001277	1.27712562767549e-11	26	0	0	252	5358
WP129	Matrix Metalloproteinases	1.00000000001348	1.34843696512454e-11	30	0	0	252	5358
WP2525	Trans-sulfuration and one carbon metabolism	1.00000000001436	1.43590352578296e-11	32	0	0	252	5358
WP727	Monoamine Transport	1.00000000001436	1.43590352578296e-11	32	0	0	252	5358
WP1471	Target Of Rapamycin (TOR) Signaling	1.00000000001497	1.49718710358119e-11	37	0	0	252	5358
WP100	Glutathione metabolism	1.0000000000152	1.52031399867841e-11	24	0	0	252	5358
WP167	Eicosanoid Synthesis	1.0000000000152	1.52031399867841e-11	24	0	0	252	5358
WP2029	Cell Differentiation - Index	1.00000000001614	1.61351545295183e-11	38	0	0	252	5358
WP383	Striated Muscle Contraction	1.00000000001614	1.61351545295183e-11	38	0	0	252	5358
WP3617	Photodynamic therapy-induced NF-kB survival signaling	1.00000000001871	1.87120002248521e-11	35	0	0	252	5358
WP558	Complement and Coagulation Cascades	1.00000000001967	1.96676994631163e-11	60	0	0	252	5358
WP1545	miRNAs involved in DNA damage response	1.00000000002021	2.0206905463667e-11	50	0	0	252	5358
WP3878	ATM Signaling Network in Development and Disease	1.00000000002044	2.04388397685474e-11	46	0	0	252	5358
WP1971	Integrated Cancer Pathway	1.00000000002044	2.04388397685474e-11	46	0	0	252	5358
WP28	Selenium Metabolism and Selenoproteins	1.00000000002044	2.04388397685474e-11	46	0	0	252	5358
WP2516	ATM Signaling Pathway	1.00000000002287	2.28733581130873e-11	40	0	0	252	5358
WP707	DNA Damage Response	1.00000000002664	2.66379736342877e-11	69	0	0	252	5358
WP2369	Histone Modifications	1.00000000002664	2.66379736342877e-11	69	0	0	252	5358
WP3624	Lung fibrosis	1.00000000002952	2.95170036265628e-11	63	0	0	252	5358
